Legal Notice—READ THIS! ASK BPI FOR FURTHER AND UPDATED INFORMATION. DO NOT RELY SOLELY UPON THIS OVERVIEW. This Management Presentation (“Presentation” or “Overview”) and any accompanying materials contain data provided by Balanced Pharma Incorporated (“BPI”). It may not be used for any other purpose except to assist the recipient in determining whether to proceed with further investigation of BPI. THIS INFORMATION IS CONFIDENTIAL AND INTENDED ONLY FOR THE RECIPIENT. By accepting these materials, the recipient agrees to keep the information contained herein confidential and not disclose its contents to third parties or to photocopy, reproduce or distribute to others at any time without the prior written consent of BPI. THIS OVERVIEW DOES NOT CONSTITUTE AN OFFER OR INVITATION FOR THESALE OR PURCHASE OF SECURITIES OR ANY OF THE BUSINESSES OR ASSETS DESCRIBED HEREIN. NOTWITHSTANDING ANY OTHER PROVISION, THIS OVERVIEW IS INTENDED ONLY FOR “ACCREDITED INVESTORS”. Accredited Investors are defined by Rule 501 of Regulation D under the U.S. Securities Act of 1933, as amended, and can bear the risk of investment losses including the potential loss of their entire investment. ANY BPI PRODUCTS MENTIONED ARE IN DEVELOPMENTAL STAGE, HAVE NOTBEEN EVALUATED OR APPROVED BY FDA OR ANY OTHER REGULATORY AUTHORITY, AND ARE NOTFOR SALE IN ANY JURISDICTION OR UNDER ANY CIRCUMSTANCE. NO REPRESENTATION OR WARRANTY, EXPRESSED OR IMPLIED, IS OR WILL BE MADE IN RELATION TO THESE MATERIALS. No responsibility or liability is or will be accepted by BPI or by any of its respective directors, officers, representatives, agents or affiliates as to or in relation to the accuracy or completeness of this overview or any other written or oral information made available to an interested party or its advisors. This Overview and any other materials provided contain forward-looking statements that are only predictions that relate to future events or BPI’s future financial performance, and involve known and unknown risks, uncertainties, and other factors that may cause BPI’s actual results, levels of activity, performance or achievements to be materially different from those implied by these forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “will,” “should,” “expects,” “intends,” “plans,” “anticipates,” “believes,” “estimates,” “predicts,” “potential,” “continue,” or the negative of these terms or other comparable terminology. STATEMENTS REGARDING COMPETITORS’ PRODUCTS AND ORGANIZATIONS, WHETHER EXPRESSED OR IMPLIED, ARE ONLY OPINIONS. The recipient should independently verify the validity of any statements about organizations or product attributes, including but not limited to the efficacy, safety, usability, availability, quality, or price of the products or the state of the organization(s) that manufacture, market, or distribute the product(s). View the offering circular at: https://www.sec.gov/Archives/edgar/data/1838860/000110465922092461/tm2223737d1_253g2.htm PRIVATE & CONFIDENTIAL